Mitochondrial dysfunction and nicotinamide dinucleotide catabolism as mechanisms of cell death and promising targets for neuroprotection
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Both acute and chronic neurodegenerative diseases are frequently associated with mitochondrial dysfunction as an essential component of mechanisms leading to brain damage. Although loss of mitochondrial functions resulting from prolonged activation of the mitochondrial permeability transition (MPT) pore has been shown to play a significant role in perturbation of cellular bioenergetics and in cell death, the detailed mechanisms are still elusive. Enzymatic reactions linked to glycolysis, the tricarboxylic acid cycle, and mitochondrial respiration are dependent on the reduced or oxidized form of nicotinamide dinucleotide [NAD(H)] as a cofactor. Loss of mitochondrial NAD+ resulting from MPT pore opening, although transient, allows detrimental depletion of mitochondrial and cellular NAD+ pools by activated NAD+ glycohydrolases. Poly(ADP‐ribose) polymerase (PARP) is considered to be a major NAD+ degrading enzyme, particularly under conditions of extensive DNA damage. We propose that CD38, a main cellular NAD+ level regulator, can significantly contribute to NAD+ catabolism. We discuss NAD+ catabolic and NAD+ synthesis pathways and their role in different strategies to prevent cellular NAD+ degradation in brain, particularly following an ischemic insult. These therapeutic approaches are based on utilizing endogenous intermediates of NAD+ metabolism that feed into the NAD+ salvage pathway and also inhibit CD38 activity. © 2011 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nakagawa, T., Shimizu, S., Watanabe, T., Yamaguchi, O., Otsu, K., Yamagata, H., Inohara, H., Kubo, T., & Tsujimoto, Y. (2005) · Nature · doi:10.1038/nature03317 · Cited by 1,635 · cited 3×
“Mitochondria from cypD null mice displayed normal respiratory functions but had a striking desensitization to Ca(21)induced damage (Basso et al., 2005; Nakagawa et al., 2005).”
Increased Nuclear NAD Biosynthesis and SIRT1 Activation Prevent Axonal Degeneration
Araki, T., Sasaki, Y., & Milbrandt, J. (2004) · Science · doi:10.1126/science.1098014 · Cited by 1,060 · cited 3×
“Regardless, all the indications are that NMN has great therapeutic potential (Araki et al., 2004; Sasaki et al., 2006).”
Mitochondria take center stage in aging and neurodegeneration
Beal, M. F. (2005) · Annals of Neurology · doi:10.1002/ana.20624 · Cited by 957
Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology
Malavasi, F., Deaglio, S., Funaro, A., Ferrero, E., Horenstein, A. L., Ortolan, E., Vaisitti, T., & Aydin, S. (2008) · Physiological Reviews · doi:10.1152/physrev.00035.2007 · Cited by 862 · cited 1×
“CD38 can also use NADP to generate nicotinic acid dinucleotide phosphate (NAADP; for review see Malavasi et al., 2008).”
Schinzel, A. C., Takeuchi, O., Huang, Z., Fisher, J. K., Zhou, Z., Rubens, J., Hetz, C., Danial, N. N., Moskowitz, M. A., & Korsmeyer, S. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505294102 · Cited by 820 · cited 1×
“An important role for MPT in mechanisms associated with ischemic brain damage is clearly supported by the dramatic reduction in infarct volume following focal ischemia in cypD knockout animals (Schinzel et al., 2005).”
Properties of the Permeability Transition Pore in Mitochondria Devoid of Cyclophilin D
Basso, E., Fante, L., Fowlkes, J., Petronilli, V., Forte, M. A., & Bernardi, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500089200 · Cited by 808 · cited 4×
“However, the PPI activity of cypD is not necessarily required for MPT induction, since the MPT pore opening can be triggered by calcium overload in mitochondria isolated from cypD null mice (Basso et al., 2005).”
InfluentialBieganowski, P., & Brenner, C. (2004) · Cell · doi:10.1016/s0092-8674(04)00416-7 · Cited by 750
The permeability transition pore complex: another view
Halestrap, A. P., McStay, G. P., & Clarke, S. J. (2002) · Biochimie · doi:10.1016/s0300-9084(02)01375-5 · Cited by 709 · cited 1×
“The MPT is characterized by opening of an inner membrane channel permeable to solutes with molecular masses of approximately 1,500 Da or lower (for review see Zoratti and Szabo, 1995; Bernardi, 1999; Bernardi et al., 2001; Crompton et al., 2002; Halestrap et al., 2002).”
Di Lisa, F., Menabò, R., Canton, M., Barile, M., & Bernardi, P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006825200 · Cited by 678 · cited 3×
“LOSS OF MITOCHONDRIAL NAD1 AS A CONSEQUENCE OF PATHOLOGIC MPT In addition to swelling, MPT also leads to depletion of the matrix pyridine nucleotides (NAD1, NADP; Di Lisa et al., 2001; Kristian and Fiskum, 2004).”
Tryptophan metabolism in the central nervous system: medical implications
Ruddick, J. P., Evans, A. K., Nutt, D. J., Lightman, S. L., Rook, G. A. W., & Lowry, C. A. (2006) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399406000068 · Cited by 519 · cited 1×
“The efficiency of de novo and salvage pathways is greater in glia compared with neurons (Ruddick et al., 2006).”
Berger, F., Lau, C., Dahlmann, M., & Ziegler, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508660200 · Cited by 508
NAD + Depletion Is Necessary and Sufficient forPoly(ADP-Ribose) Polymerase-1-Mediated Neuronal Death
Alano, C. C., Garnier, P., Ying, W., Higashi, Y., Kauppinen, T. M., & Swanson, R. A. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5552-09.2010 · Cited by 439 · cited 1×
“This notion is supported by data presented by Alano et al. (2004, 2010) showing that NAD1 depletion and MPT are sequential and necessary steps in PARP1-mediated cell death.”
Sasaki, Y., Araki, T., & Milbrandt, J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2320-06.2006 · Cited by 269
REVIEW: Vitamin transport and homeostasis in mammalian brain: focus on Vitamins B and E
Spector, R., & Johanson, C. E. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04773.x · Cited by 175
Brennan, A. M., Connor, J. A., & Shuttleworth, C. W. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600292 · Cited by 97 · cited 2×
“MITOCHONDRIAL NAD1 NAD1 is an important cofactor involved in multiple metabolic reactions (Brennan et al., 2006).”
Nicotinamide Riboside and Nicotinic Acid Riboside Salvage in Fungi and Mammals
Belenky, P., Christensen, K. C., Gazzaniga, F., Pletnev, A. A., & Brenner, C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807976200 · Cited by 95 · cited 1×
“Recently, a third vitamin precursor of NAD1 was discovered: nicotinamide riboside (NR) that is taken up by cells and phosphorylated to nicotinamide monophosphate (NMN) by NR kinases (Nrk1 and Nrk2; Bieganowski and Brenner, 2004; Belenky et al., 2009).”
Saccharomyces cerevisiae YOR071C Encodes the High Affinity Nicotinamide Riboside Transporter Nrt1
Belenky, P. A., Moga, T. G., & Brenner, C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800021200 · Cited by 78
Cited by
Regulated necrosis: the expanding network of non-apoptotic cell death pathways
Berghe, T. V., Linkermann, A., Jouan-Lanhouet, S., Walczak, H., & Vandenabeele, P. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3737 · Cited by 1,735
The dynamic regulation of NAD metabolism in mitochondria
Stein, L. R., & Imai, S.-I. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.06.005 · Cited by 535
Nicotinamide mononucleotide inhibits JNK activation to reverse Alzheimer disease
Yao, Z., Yang, W., Gao, Z., & Jia, P. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.03.027 · Cited by 140
Long, A., Park, J. H., Klimova, N., Fowler, C., Loane, D. J., & Kristian, T. (2017) · Neurochemical Research · doi:10.1007/s11064-016-2031-9 · Cited by 44
“We have shown that CD38 activity increases in brain tissue following ischemic insult [11] and effectively depletes brain tissue of NAD+ [17].”
Metadata
- Authors
- Kristian, T., Balan, I., Schuh, R., & Onken, M.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2011-04-12
- Volume
- 89
- Issue
- 12
- Pages
- 1946-1955
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2170359617
- Cited by
- 48
- References
- 17
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.